LSA
CDMO

Leonteq Securities AG’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Leonteq Securities AG’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-500
Closed -$9.12K – 1142
2021
Q1 		$9.12K Buy
+500
New +$8.31K ﹤0.01% 932

Other funds holding CDMO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Leonteq Securities AG's CDMO Position: Q2 2021 in Review

Leonteq Securities AG sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q2 2021, closing a stake of 500 shares — an estimated $9.12K sold.

Leonteq Securities AG first reported a position in CDMO in Q1 2021 and held it in 1 quarter. The position peaked at $9.12K in Q1 2021. 172 funds tracked by Wall St. Rank hold CDMO as of Q2 2021.

  • Leonteq Securities AG reported no remaining Avid Bioservices, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Leonteq Securities AG sold 500 Avid Bioservices, Inc. Common Stock shares in Q2 2021, an estimated $9.12K.
  • Leonteq Securities AG first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Leonteq Securities AG's Avid Bioservices, Inc. Common Stock position peaked at $9.12K in Q1 2021.
  • 172 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q2 2021.

Based on Leonteq Securities AG's 13F filing for Q2 2021, filed 26 Mar 2026.